Efficacy and Safety of Oral Factor XIa Inhibitors in Stroke Prevention: A Systematic Review and Meta-Analysis
Introduction: Despite preventive measures, stroke rates remain high in the primary and secondary prevention settings. Factor XIa inhibition may offer a novel, safe and effective antithrombotic option for stroke prevention. Methods: We conducted a systematic review and meta-analysis including all ava...
Main Authors: | Lina Palaiodimou, Georgia Papagiannopoulou, Aristeidis H. Katsanos, Andreas Eleftheriou, Theodore Karapanayiotides, Panayiotis D. Mitsias, Robin Lemmens, Carlos A. Molina, Andrei Alexandrov, Valeria Caso, Ashkan Shoamanesh, Mukul Sharma, Georgios Tsivgoulis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/17/5562 |
Similar Items
-
Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys
by: Pancras C. Wong, et al.
Published: (2021-05-01) -
Lignosulfonic Acid Sodium Is a Noncompetitive Inhibitor of Human Factor XIa
by: Srabani Kar, et al.
Published: (2021-08-01) -
Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia
by: Srabani Kar, et al.
Published: (2020-11-01) -
A Factor XIa Inhibitor Engineered from Banded Krait Venom Toxin: Efficacy and Safety in Rodent Models of Arterial and Venous Thrombosis
by: Wei Seng Chng, et al.
Published: (2022-07-01) -
Miaodigounization and Erlitounization: the formation and evolution of the Hua-Xia ethnic group and Hua-Xia tradition from the perspective of archaeology
by: Cao Bingwu
Published: (2022-05-01)